COMMUNIQUÉS West-GlobeNewswire

CeGaT receives California CLIA State License and Accreditation - expanding diagnostic services in California
02/01/2019
BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- CeGaT GmbH is a CLIA certified laboratory for high complexity testing (CLIA# 99D2130225) approved by US authorities (Centers of Medicare & Medicaid Services- [...]
Amedisys to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
BATON ROUGE, La., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced that Paul B. Kusserow, President and Chief Executive [...]
Creso Looks to Capitalize on Domestic & Foreign Legislation -- CFN Media
02/01/2019
SEATTLE, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Exagen enters second-year agreement with GSK to drive greater awareness about challenges facing lupus diagnosis and management
02/01/2019
Albuquerque, NM and San Diego, CA, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in rheumatology testing, today announced that it has extended its agreement with GSK, one of the world’s leading healthcare companies [...]
NICOX : Number of voting rights as of December 31.2018
02/01/2019
Nicox SA Société anonyme with a registered capital of € 29,715,320 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On January 2, 2019, MONTHLY PUBLICATION OF THE [...]
NICOX : Nombre de droits de vote au 31 décembre 2018
02/01/2019
Nicox SA Société anonyme au capital de 29 715 320 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 2 janvier 2019, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Merus annonce une collaboration stratégique avec Betta Pharmaceuticals pour développer et commercialiser le MCLA-129 en Chine
02/01/2019
Merus conserve tous les droits à l’échelle mondiale hors Chine Betta Pharmaceuticals financera les activités mondiales nécessaires à la soumission d'une IND UTRECHT (Pays-Bas), 02 janv. 2019 (GLOBE NEWSWIRE) -- Merus N. [...]
Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construct 150 Homes
02/01/2019
TORONTO, ON, Jan. 02, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) Announces that it has closed on a Construction Agreement and has started operations on a $2,600,000 CDN framing [...]
Holding(s) in Company
02/01/2019
Holding(s) in Company January 2, 2019 – Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii : Shire Plc JE00B2QKY057 1b. [...]
OraSure Technologies, Inc.: Updated Release to Clarify Timing of Presentation
02/01/2019
OraSure Technologies to Present at the 37th Annual J.P. Morgan Healthcare Conference BETHLEHEM, Pa., Jan. 02, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic [...]
Cambrex Completes Acquisition of Avista Pharma Solutions
02/01/2019
EAST RUTHERFORD, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage [...]
Coherus BioSciences Appoints Darlene Horton, M.D., Chief Medical and Regulatory Affairs Officer
02/01/2019
REDWOOD CITY, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced the addition of Darlene Horton, M.D. as Chief Medical and Regulatory Affairs Officer. She assumed her [...]
Coherus BioSciences Management to Present at The 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
REDWOOD CITY, Calif., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that senior management will present at the 37 th annual J.P. Morgan healthcare conference on Tuesday, [...]
Outlook Therapeutics Closes Third Tranche of $20 Million Private Placement
02/01/2019
CRANBURY, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the “Company”) today announced that it closed on the third tranche (of four) of its $20.0 million private placement of common [...]
Cerner to Present at 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
KANSAS CITY, Mo, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) announced today that Chairman and CEO Brent Shafer and Executive Vice President and Chief Financial Officer Marc Naughton will present [...]
Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System
02/01/2019
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]
Innovation Pharmaceuticals Receives New Brilacidin Patent, Further Expanding Intellectual Property Estate
02/01/2019
BEVERLY, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, reported today that the U.S. Patent & Trademark Office recently [...]
Oxford Immunotec to Present at the 37th Annual J.P. Morgan Healthcare Conference
02/01/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief [...]
Obalon Announces Promotion of Kelly Huang, Ph.D. To Chief Executive Officer
02/01/2019
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN ), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric [...]

Pages